Meningococcal disease peaks in the late winter and early spring. Complications in survivors may include hearing loss, kidney failure, amputation of the limbs, and permanent brain injury. Meningococcal infection may, in some cases, be fatal. It does not protect against serogroup B. Side effects of the vaccine are minimal and may include pain and redness at the injection site. Decision about whether to receive or not receive the immunization should be based on knowledge of those at risk.
Meningococcal disease can affect people at any age.
Groups at increased risk include those in close contact with a known case, patients with compromised immunity, and persons traveling to endemic areas of the world. The Centers for Disease Control and American Academy of Pediatrics do not recommend that meningococcal vaccine be given routinely. The American College Health Association recommends that college students consider vaccination to reduce the risk of meningococcal disease. In summary, seek medical care if there are any signs or symptoms of meningitis. Know that there is a vaccine available that may be protective.